Ryan Saadi's most recent trade in Tevogen Bio Holdings Inc. was a trade of 8,000,000 Common Stock done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 8,000,000 | 124,814,453 | - | 0 | Common Stock | |
| Tevogen Bio Holdings Inc. | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 09 Jun 2025 | 1,438,206 | 116,814,453 | - | 1.2 | 1,768,993 | Common Stock |
| Tevogen Bio Holdings Inc. | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 05 Jun 2024 | 2,607 | 118,252,659 | - | 0.8 | 2,000 | Common Stock |
| Tevogen Bio Holdings Inc. | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 98,901,098 | 98,901,098 | - | - | Common Stock | |
| Tevogen Bio Holdings Inc. | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 19,348,954 | 118,250,052 | - | 0 | Common Stock | |
| Tevogen Bio Holdings Inc. | Ryan Saadi | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 193,923 | 193,923 | - | - | Common Stock |